Gastroenterology Book


Cancer Antigen 19-9

Aka: Cancer Antigen 19-9, CA 19-9
  1. Pathophysiology
    1. Cancer Antigen 19-9 is expressed in pancreatic disease and hepatobiliary disease
  2. Indications
    1. Pancreatic ductal adenocarcinoma
      1. Confirms diagnosis
      2. Predicts prognosis as well as recurrence risk
    2. Not indicated for screening in asymptomatic patients
      1. No tumor specific (see efficacy below)
  3. Causes: Increased CA 19-9
    1. Pancreatic Ductal Adenocarcinoma
    2. Chronic Pancreatitis
    3. Chronic inflammatory states
  4. Efficacy: Pancreatic Ductal Adenocarcinoma
    1. Test Sensitivity: 50-75%
    2. Test Specificity: 80-85%
  5. References
    1. Safi (1987) Pancreas 2(4): 398-403 [PubMed]

You are currently viewing the original '\legacy' version of this website. Internet Explorer 8.0 and older will automatically be redirected to this legacy version.

If you are using a modern web browser, you may instead navigate to the newer desktop version of fpnotebook. Another, mobile version is also available which should function on both newer and older web browsers.

Please Contact Me as you run across problems with any of these versions on the website.

Navigation Tree